Multiply Labs has reached an agreement with pharmaceutical giant AstraZeneca to evaluate the potential for applying GMP (Good Manufacturing Practices)-ready robotic systems to commercial-scale cell therapy manufacturing. Multiply Labs is a specialist in autonomous manufacturing technology for advanced therapies.
The collaboration will focus on end-to-end robotic automation of industry-standard instruments used in cell therapy production using Multiply Labs’ robotic biomanufacturing system.
The goal is to enable scalable, high-throughput manufacturing while maintaining the rigorous quality and regulatory standards required for clinical and commercial use. [Read more…] about Multiply Labs partners with AstraZeneca to automate cell therapy manufacturing with robotics
